Crossmark

Navigating the Path to Inclusion: Understanding Barriers and Facilitators to Clinical Trial Participation Among Chinese Older Adults in the United States with Multimorbidity

Crossref DOI link: https://doi.org/10.1007/s11606-024-09162-2

Published Online: 2024-11-04

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tarn, Derjung M. https://orcid.org/0000-0001-7426-6387
Liu, Ruey-Ying

Pun, Ting

Schwartz, Janice B.
Funding

Funding for this research was provided by:

Food and Drug Administration (U01FD005978)

National Institute on Aging (R24AG063718)

National Center for Advancing Translational Sciences (UL1TR001881, UL1TR001872)
License Information

Text and Data Mining valid from 2024-11-04

Version of Record valid from 2024-11-04
More Information

Article History

Received: 14 May 2024

Accepted: 17 October 2024

First Online: 4 November 2024

Declarations:

:

: Dr. Tarn and Dr. Schwartz have previously been funded for unrelated research by investigator-initiated research awards from Bristol-Myers Squibb and Pfizer, as part of the American Thrombosis Investigator Initiated Research Program (ARISTA-USA). Dr. Liu and Dr. Pun report no conflicts of interest.

: This article reflects the views of the authors and should not be construed to represent the FDA or NIH’s views or policies.

Document is current

Any future updates will be listed below